Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluated the safety and preliminary efficacy of Ariva Silver Wintergreen in reducing cigarette craving among individuals with tobacco use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Ariva Silver Wintergreen (smoking aversive lozenge)

Snippet

Sponsor: Star Scientific, Inc | Conditions: Tobacco Use Disorder, Smoking | Phase 1 | Status: COMPLETED